Method Article

Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor

DOI:

10.3791/63853

May 2nd, 2022

In This Article

Summary

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The goal of this manuscript is to describe the KitV558Δ/+ mouse model and techniques for successful dissection and processing of mouse specimens.

Abstract

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Gastrointestinal stromal tumor (GIST) is the most common human sarcoma and is typically driven by a single mutation in the KIT receptor. Across tumor types, numerous mouse models have been developed in order to investigate the next generation of cancer therapies. However, in GIST, most in vivo studies use xenograft mouse models which have inherent limitations. Here, we describe an immunocompetent, genetically engineered mouse model of gastrointestinal stromal tumor harboring a KitV558Δ/+ mutation. In this model, mutant KIT, the oncogene responsible for most GISTs, is driven by its endogenous promoter leading to a GIST which mimics the histological appearance and immune infiltrate seen in human GISTs. Furthermore, this model has been used successfully to investigate both targeted molecular and immune therapies. Here, we describe the breeding and maintenance of a KitV558Δ/+ mouse colony. Additionally, this paper details the treatment and procurement of GIST, draining mesenteric lymph node, and adjacent cecum in KitV558Δ/+ mice, as well as sample preparation for molecular and immunologic analyses.

Introduction

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

GIST is the most common sarcoma in humans with an incidence of about 6,000 cases in the United States of America1. GIST appears to originate from the gastrointestinal pacemaker cells named the interstitial cells of Cajal, and is typically driven by a single mutation in the tyrosine kinase KIT or PDGFRA2. Surgery is the mainstay of treatment for GIST and can be curative, but patients with advanced disease may be treated with the tyrosine kinase inhibitor (TKI), imatinib. Since its introduction over 20 years ago, imatinib has transformed the treatment paradigm in GIST, improving the survival in advanc....

Access restricted. Please log in or start a trial to view this content.

Protocol

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

All mice were housed under pathogen-free conditions at the University of Pennsylvania according to NIH guidelines and with approval of the University of Pennsylvania IACUC. Euthanasia was performed following the University of Pennsylvania Laboratory Animal Resources standard operating procedures.

1. KitV558Δ/+ mouse breeding

  1. Backcross the KitV558Δ/+ mice more than 10 times onto a C57BL/6J background using C57BL/6J mice. To do this, breed the male KitV558Δ/+ mice with female C57BL/6J mice at a 1:2 ratio.

Access restricted. Please log in or start a trial to view this content.

Results

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The KitV558Δ/+ mouse model allows for the investigation of therapeutics in an immunocompetent mouse model. KitV558Δ/+ mice have an average lifespan of 8 months due to progressive bowel obstruction (Figure 4). Tumors from KitV558Δ/+ mice express canonical markers of GIST including the tyrosine kinase KIT and the transmembrane channel DOG1 (Figure 5

Access restricted. Please log in or start a trial to view this content.

Discussion

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The KitV558Δ/+ mouse model is a powerful research tool in the molecular and immunologic analysis of GIST. Although the breeding strategy requires a single cross, using KitV558Δ/+ mouse cohorts in experiments analyzing tumor response requires extensive breeding. Mice should be age- and sex-matched to ensure similar tumor weights, and 10% of mice die before 8 weeks of age when tumors are established. Less extensive breeding strategies are possible if using advanced ima.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The authors have no conflicts of interest to disclose.

Acknowledgements

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

KitV558Δ/+ mice were genetically engineered and shared by Dr. Peter Besmer10. This work was supported by NIH grants R01 CA102613 and T32 CA251063.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
100 micron filterEMSCO1194-2360
1x RBC lysis bufferLife Technologies00-4333-57
3mL syringeThermo Fisher Scientific/BD Biosciences14823435
4–15% Mini-PROTEAN TGX Precast Protein Gels, 10-well, 30 µlBio-Rad4561083
4% Paraformaldehyde SolutionThermo Fisher ScientificAAJ19943K2
40 micron filterEMSCO1194-2340
5M NaClSigma AldrichS6546
70 micron filterEMSCO1194-2350
AKT antibody (C67E7)Cell Signaling4691
C57BL/6J miceThe Jackson Laboratory
Collagenase IVSigma AldrichC5138
Complete mini edta free protease inhibitorThomas ScientificC852A34
Countess II Automated Cell CounterThermo Fisher Scientific
Disposable ScalpelsThermo Fisher Scientific/Exel International14-840-00
Dnase IThomas ScientificC756V81
Dog1 antibodyabcamab64085
EDTASigma AldrichE9884
ERK antibody (p44/42)Cell Signaling9102
FBSThomas ScientificC788U23
FIJI softwareFIJIhttps://imagej.net/software/fiji
Fisherbrand 850 HomogenizerThermo Fisher Scientific15-340-169
HBSSUniversity of Pennsylvania Cell Center
Imatinib mesylateSelleck ChemicalsS1026
KIT antibody (D13A2)Cell Signaling3074
KitV558Δ/+ GenotypingTransnetyx
Microcentrifuge tubes (1.5mL)Thermo Fisher Scientific05-408-129
Mouse on Mouse Immunodetection Kit, BasicVector LaboratoriesBMK-2202
Nitrocellulose Membrane, Precut, 0.45 µmRio-Rad1620145
Nonfat Dry MilkThermo Fisher ScientificNC9121673
Nonidet P 40 SubstituteSigma Aldrich74385
p-AKT antibody (S473)Cell Signaling4060
p-ERK antibody (p44/42)Cell Signaling9101
p-KIT antibody (Y719)Cell Signaling3391
PMSF Protease InhibitorThermo Fisher Scientific36978
Proeinase KThermo Fisher ScientificBP170050
Round-Bottom Polystyrene Test (FACS) TubesFalcon/Thermo Fisher Scientific14-959-2A
RPMIUniversity of Pennsylvania Cell Center
Sodium fluoride (NaF)Sigma Aldrich201154
Sodium orthovanadate (Na3VO4)Sigma AldrichS6508
SuperSignal West Dura Extended Duration SubstrateThermo Fisher Scientific34076
TBS buffer (10x)University of Pennsylvania Cell Center
Tissue culture dish (100mm2)Thermo Fisher Scientific/Falcon08-772E
TrisHCLThermo Fisher ScientificBP1757500
Tween 20Rio-Rad1706531
 vivaCT 80 platformScanco medical

References

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,
  1. Mastrangelo, G., et al. Incidence of soft tissue sarcoma and beyond: a population-based prospective study in 3 European regions. Cancer. 118 (21), 5339-5348 (2012).
  2. Joensuu, H., DeMatteo, R. P.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Tags

Gastrointestinal Stromal TumorGenetically Engineered MiceImmunocompetent Mouse ModelKit MutationTumor MicroenvironmentFlow CytometrySingle Cell SuspensionProtein IsolationTyrosine Kinase InhibitorsTumor Dissection

Related Articles